BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36622564)

  • 1. Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer.
    Ma J; Wang F; Chen C; Ji J; Huang P; Wei D; Zhang Y; Ren L
    Breast Cancer; 2023 May; 30(3):379-392. PubMed ID: 36622564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
    Dong Q; Han Z; Tian L
    Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of lncRNA/circRNA-miRNA-mRNA in the proliferative phase of liver regeneration in mice with liver fibrosis.
    Wang Q; Long Z; Zhu F; Li H; Xiang Z; Liang H; Wu Y; Dai X; Zhu Z
    BMC Genomics; 2023 Jul; 24(1):417. PubMed ID: 37488484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
    Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P
    Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.
    Huang Y; Wang X; Zheng Y; Chen W; Zheng Y; Li G; Lou W; Wang X
    Aging (Albany NY); 2021 Jan; 13(1):1153-1175. PubMed ID: 33428596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic metastasis-associated circRNA‒miRNA‒mRNA network for exploring the pathogenesis and therapeutic target of triple negative breast cancer based on whole-transcriptome sequencing analysis: an experimental verification study.
    Luo J; Cao D; Hu C; Liang Z; Zhang Y; Lai J
    J Transl Med; 2022 Nov; 20(1):508. PubMed ID: 36335337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease.
    Liu P; Wang Y; Zhang N; Zhao X; Li R; Wang Y; Chen C; Wang D; Zhang X; Chen L; Zhao D
    Respir Res; 2022 Jun; 23(1):154. PubMed ID: 35690768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Investigation of circRNA-associated ceRNA Regulatory Network in Molecular Subtypes of Breast Cancer.
    Zhong Y; Pan S; Zhi S; Li Y; Xiu Z; Wei C; Luo J
    Curr Comput Aided Drug Des; 2022; 18(3):185-195. PubMed ID: 35708093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and Bioinformatics Analysis of Competitive Endogenous RNA Regulatory Network --Related to Circular RNA in Breast Cancer.
    Wang T; Zhang Y; He Y; Liu Y; Qi P
    Biomed Res Int; 2021; 2021():5575286. PubMed ID: 34545330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
    Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
    BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of atrial fibrillation-related circRNA/lncRNA-miRNA-mRNA regulatory network and analysis of potential biomarkers.
    Wen JL; Ruan ZB; Wang F; Chen GC; Zhu JG; Ren Y; Zhu L
    J Clin Lab Anal; 2023 Jan; 37(2):e24833. PubMed ID: 36604807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
    Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
    Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
    Yang L; Ma TJ; Zhang YB; Wang H; An RH
    Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.